ARCHIVES

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

This article is from The Cancer Letter archive.

Vol. 31 No. 6 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

$5 Million Lift Raises Payline From 180 to 185

May 21, 1982

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More

March 29, 1996

NIH Limits Salaries On Grants, Contracts ACS Clinical Awards Available For 1995

February 25, 1994